NLS Pharmaceutics (NLSP) has released an update.
NLS Pharmaceutics AG, a Kloten-based stock corporation, has announced its share capital details, revealing a capital band with an upper limit of CHF 3,979,498.80. The board is authorized to increase share capital at any time until November 8, 2029, potentially issuing up to 1,658,124 fully paid common shares. Investors interested in pharmaceutical development might find this an intriguing opportunity for portfolio diversification.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
